NAYA Biosciences Inc.

NASDAQ: NAYA · Real-Time Price · USD
2.20
0.17 (8.37%)
At close: Apr 25, 2025, 3:59 PM

NAYA Biosciences Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
6.59M 6.53M 6.23M 5.77M 4.25M 3.02M 1.92M 1.18M 1.01M 822.2K 3.59M 3.58M 3.64M 4.16M 1.31M 1.43M 1.46M
Cost of Revenue
3.85M 3.66M 3.59M 3.18M 2.57M 1.86M 1.12M 713.4K 601.5K 593.24K 563.41K 438.29K 340.92K 273.68K 168.66K 146.49K 121.51K
Gross Profit
2.74M 2.87M 2.64M 2.59M 1.68M 1.16M 797.29K 463.99K 406.12K 228.95K 3.03M 3.14M 3.3M 3.89M 1.14M 1.28M 1.34M
Operating Income
-24.29M -8.13M -5.66M -5.24M -5.41M -6.77M -7.98M -9.62M -10.23M -10.63M -7.4M -7.15M -6.36M -5.22M -7.51M -6.5M -5.68M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 34.00 82.00 307.00 369.00 335.00 2.71K 4.5K 8.63K 8.63K 6.2K
Pretax Income
-24.93M -9.12M -7.41M -7.06M -7.05M -8.01M -8.8M -10.1M -10.67M -10.89M -8.02M -7.95M -6.97M -6.65M -10.56M -9.85M -9.36M
Net Income
-24.9M -9.1M -7.47M -7.08M -7.08M -8.03M -8.81M -10.11M -10.67M -10.89M -8.27M -7.96M -6.98M -6.65M -10.32M -9.85M -9.36M
Selling & General & Admin
10.19M 9.08M 7.46M 7.2M 6.6M 7.6M 8.52M 9.67M 10.12M 10.31M 9.9M 9.88M 9.4M 8.89M 8.27M 7.35M 6.59M
Research & Development
750.44K 489.66K 10.79K 13.46K 97.31K 165.94K 233.87K 406.47K 513.38K 544.04K 533.96K 414.09K 254.34K 216.43K 373.61K 430.77K 434.64K
Other Expenses
16.08M 1.43M 829.39K 619.4K 389.06K 162.1K 20.5K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
27.03M 11M 8.3M 7.83M 7.08M 7.93M 8.77M 10.08M 10.64M 10.86M 10.43M 10.29M 9.65M 9.1M 8.65M 7.78M 7.02M
Interest Expense
1.19M 1.06M 1.01M 1.09M 890.62K 925.91K 799.99K 449.67K 274.58K 59.45K 189.78K 280.57K 371.59K 1.27M 3.1M 3.52M 3.68M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
30.88M 14.66M 11.89M 11.01M 4.89M -284.92K -6.17M -10.79M -11.24M -11.45M -11M -10.73M -10M -9.38M -8.82M -7.93M -7.14M
Income Tax Expense
-24.75K -22.91K 54.13K 26.76K 29.62K 27.79K 6.82K 4.94K 2.87K 2.87K 5.56K 5.56K 4.76K 4.76K 36.00 36.00 36.00
Shares Outstanding (Basic)
309.54K 309.54K 323.83K 3.61M 3.8M 2.49M 3.55M 2.93M 2.49M 2.43M 2.43M 2.42M 2.41M 2.39M 2.09M 2.09M 1.98M
Shares Outstanding (Diluted)
309.54K 309.54K 323.83K 3.61M 3.8M 2.49M 3.55M 2.93M 2.49M 2.43M 2.43M 2.42M 2.41M 2.39M 2.09M 2.09M 1.98M
EPS (Basic)
-70.92 -15.12 -6.88 -2.54 -3.45 -5.08 -6.56 -7.95 -8.73 -8.99 -6.83 -6.88 -6.3 -6.48 -12.37 -15.96 -16.9
EPS (Diluted)
-70.92 -15.12 -6.88 -2.54 -3.45 -5.08 -6.56 -7.95 -8.73 -8.99 -6.83 -6.88 -6.3 -6.48 -12.37 -15.96 -16.9
EBITDA
-22.81M -7.14M -5.58M -5.35M -5.75M -6.82M -7.81M -9.4M -10.08M -10.52M -7.52M -7.41M -6.38M -5.23M -7.38M -6.28M -5.64M
EBIT
-23.74M -8.06M -6.41M -5.97M -6.16M -7.08M -8M -9.65M -10.39M -10.83M -7.83M -7.67M -6.6M -5.38M -7.46M -6.34M -5.67M
Depreciation & Amortization
927.11K 919.6K 829.39K 619.4K 408.77K 258.75K 194.71K 251.31K 310.82K 306.32K 308.12K 262.6K 214.94K 151.05K 80.31K 57.54K 34.53K